Costs to Consider Before Dropping the Medicare Advantage Plan Completely

Costs to Consider Before Dropping the Medicare Advantage Plan Completely

FatCamera | E+ | Getty Images For some Medicare beneficiaries, a benefit plan ends up not being a good fit. If you’re in this situation and are considering dropping your plan to return to basic Medicare — Part A (hospital coverage) and Part B (outpatient services) — there are some things to consider before you … Read more

CVS Pays $5 Billion to Settle Opioid Lawsuits

CVS Pays $5 Billion to Settle Opioid Lawsuits

CVS health corp. CVS -0.08% has agreed to pay about $5 billion in a landmark settlement that the company says will resolve all remaining opioid crisis lawsuits filed by states, cities and other governments. The largest U.S. drugstore company is the first pharmacy chain to reach a settlement in the collection of lawsuits filed by … Read more

How Congress and Business Can Help Stop Inflation

How Congress and Business Can Help Stop Inflation

Americans look to the nation’s most powerful bank, the Federal Reserve, to fight inflation. “I think our biggest problem, at least for the foreseeable future, is high inflation,” Mark Zandi, chief economist at Moody’s Analytics, told CNBC. The Fed can raise interest rates to slow inflation, which ultimately makes the cost of borrowing higher for … Read more

RSV vaccine protected infants from severe cases, Pfizer study shows

RSV vaccine protected infants from severe cases, Pfizer study shows

An experimental vaccine from Pfizer Inc. significantly reduced the risk of infants developing severe cases of a respiratory virus that kills hundreds of children each year, according to the company. Among mothers who received the respiratory syncytial virus vaccine, their infants had an 81.8% lower risk of developing serious lower respiratory infections that required medical … Read more

Pfizer’s earnings are Tuesday. What to see.

Pfizer’s earnings are Tuesday.  What to see.

Pfizer is set to report earnings on Tuesday, a week and a half after an executive told investors the company was considering a list price for its Covid-19 vaccine of between $110 and $130 per adult dose, higher than analysts had expected. The surprise has prompted analysts to rethink their estimates for next year’s Covid-19 … Read more

The Bivalent Booster Boondoggle – WSJ

The Bivalent Booster Boondoggle – WSJ

Pfizer Vaccines. Photo: Pfizer/Associated Press The public health bureaucracy adopts yet another excessive vaccination policy. On October 12, the Food and Drug Administration approved bivalent Covid-19 boosters from Pfizer and Moderna for use in children as young as 5 and 6 years, respectively. That same day, the Centers for Disease Control and Prevention recommended the … Read more

Biotech co-founder faces murder-for-hire charges accused of fabricating data

Biotech co-founder faces murder-for-hire charges accused of fabricating data

Enochian BioSciences Inc. has sued co-founder Serhat Gumrukcu for contractual fraud, alleging it paid him and his husband $25 million based on scientific data that Mr. Gumrukcu altered and fabricated. A lawyer for Mr. Gumrukcu did not immediately respond to a request for comment on the Enochian trial. Enochian is seeking repayment of all payments … Read more

Pfizer aims for Covid vaccine price of at least $110 per dosage

Pfizer aims for Covid vaccine price of at least $110 per  dosage

Pfizer Inc. gave some details about its plans to sell the Covid-19 vaccine it developed with BioNTech SE on the commercial market in the United States, saying it expects to price the shot at $110 to $130 per dose for adults. The drugmaker is still negotiating with health insurers but expects the discussions to lead … Read more

Covid Boosters are not for everyone

Covid Boosters are not for everyone

Covid vaccines are administered in Miami, August 4. Photo: Marta Lavandier/Associated Press How safe are the Covid-19 vaccines? During my leadership, the Florida Department of Health analyzed the overall mortality and cardiac mortality risk associated with Covid-19 vaccination. We found an 84% increase in the relative incidence of cardiac-related death among men 18 to 39 … Read more

FDA approves Novavax Covid-19 Shot as booster for adults

FDA approves Novavax Covid-19 Shot as booster for adults

The Food and Drug Administration gave Novavax emergency approval Inc.’s Covid-19 shot as a booster for adults. The shot targets the original strain of the virus, whereas the updated booster shots from Moderna Inc. and Pfizer Inc. and its partner BioNTech SE, approved in August by the FDA, targeting both the original strain and newer … Read more